TAM
ENTA icon

THB Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

THB Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,568
Closed -$220K – 161
2019
Q4 		$220K Hold
3,568
– – 0.04% 160
2019
Q3 		$214K Sell
3,568
-4
-0.1% -$297 0.04% 161
2019
Q2 		$301K Hold
3,572
– – 0.05% 154
2019
Q1 		$341K Buy
+3,572
New +$320K 0.05% 154

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

THB Asset Management's ENTA Position: Q1 2020 in Review

THB Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2020, closing a stake of 3,568 shares — an estimated $220K sold.

THB Asset Management first reported a position in ENTA in Q1 2019 and held it in 4 quarters. The position peaked at $341K in Q1 2019. 155 funds tracked by Wall St. Rank hold ENTA as of Q1 2020.

  • THB Asset Management reported no remaining Enanta Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • THB Asset Management sold 3,568 Enanta Pharmaceuticals shares in Q1 2020, an estimated $220K.
  • THB Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • THB Asset Management's Enanta Pharmaceuticals position peaked at $341K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2020.

Based on THB Asset Management's 13F filing for Q1 2020, filed 6 May 2020.